Design, synthesis and inhibitory activities of 8-(substituted styrolformamido) phenyl-xanthine derivatives on monoamine oxidase B

Chemical and Pharmaceutical Bulletin

Volumn 60, Issue 3, 2012, Pages 385-390

  Hu, Suwen ^a   Nian, Siyun ^a   Qin, Kuiyou ^a   Xiao, Tong ^a   Li, Ngna ^a   Qi, Xiaolu ^a   Ye, Faqing ^a   Liang, Guang ^a   Hu, Guoxin ^a   He, Jincai ^a   Yu, Yinfei ^a   Song, Bo ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Monoamine oxidase B inhibition activity; Substituent effect; Xanthine derivative

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; FLUORINE; N (3 (1,3 DIMETHYL 2,6 DIOXO 2,3,6,7 TETRAHYDRO 1H PURIN 8 YL) 3 (4 FLUOROPHENYL)ACRYLAMIDE; UNCLASSIFIED DRUG; XANTHINE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; DRUG DESIGN; DRUG INHIBITION; DRUG SELECTIVITY; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME INHIBITION; IN VITRO STUDY; MOUSE; NONHUMAN;

FLUORINE; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; STRUCTURE-ACTIVITY RELATIONSHIP; STYRENE; XANTHINE;

EID: 84863405414     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.60.385     Document Type: Article

References (23)

1. Petzer J. P., Steyn S., Castagnoli K. P., Chen J. F., Schwarzschild M. A., Van der Schyf C. J., Castagnoli N., Bioorg. Med. Chem., 11, 1299-1310 (2003).
2. Pretorius J., Malan S. F., Castagnoli N. Jr., Bergh J. J., Petzer J. P., Bioorg. Med. Chem., 16, 8676-8684 (2008).
3. Dauer W., Przedborski S., Neuron, 39, 889-909 (2003).
4. Schwarzschild M. A., Agnati L., Fuxe K., Chen J. F., Morelli M., Trends Neurosci., 29, 647-654 (2006).
5. Dauer W., Przedborski S., Neuron, 39, 889-909 (2003).
6. Gentili F., Pizzinat N., Ordener C., Marchal-Victorion S., Maurel A., Hofmann R., Renard P., Delagrange P., Pigini M., Parini A., Giannella M., J. Med. Chem., 49, 5578-5586 (2006).
7. Pålhagen S., Heinonen E., Hägglund J., Kaugesaar T., Mäki-Ikola O., Palm R.; Swedish Parkinson Study Group, Neurology, 66, 1200-1206 (2006).
8. Di Santo R., Costi R., Roux A., Artico M., Befani O., Meninno T., Agostinelli E., Palmegiani P., Turini P., Cirilli R., Ferretti R., Gallinella B., La Torre F., J. Med. Chem., 48, 4220-4223 (2005).
9. Gökhan-Kelekçi N., Koyunoǧlu S., Yabanoǧlu S., Yelekçi K., Ozgen O., Uçar G., Erol K., Kendi E., Yeşilada A., Bioorg. Med. Chem., 17, 675-689 (2009).
10. Cohen G., Spina M. B., Ann. Neurol., 26, 689-690 (1989).
11. Kitani K., Minami C., Isobe K., Maehara K., Kanai S., Ivy G. O., Carrillo M. C., Mech. Ageing Dev., 123, 1087-1100 (2002).
12. Youdim M. B., Riederer P. F., Neurology, 63 (7 Suppl. 2), 32-35 (2004).
13. Chiba K., Trevor A., Castagnoli N. Jr., Biochem. Biophys. Res. Commun., 120, 574-578 (1984).
14. Koga K., Kurokawa M., Ochi M., Nakamura J., Kuwana Y., Eur. J. Pharmacol., 408, 249-255 (2000).
15. Gołembiowska K., Dziubina A., Kowalska M., Kamińska K., Neurotox. Res., 15, 155-166 (2009).
16. Toprakçí M., Yelekçi K., Bioorg. Med. Chem. Lett., 15, 4438-4446 (2005).
17. Vlok N., Malan S. F., Castagnoli N. Jr., Bergh J. J., Petzer J. P., Bioorg. Med. Chem., 14, 3512-3521 (2006).
18. Suzuki F., Shimada J., Shiozaki S., Ichikawa S., Ishii A., Nakamura J., Nonaka H., Kobayashi H., Fuse E., J. Med. Chem., 36, 2508-2518 (1993).
19. van den Berg D., Zoellner K. R., Ogunrombi M. O., Malan S. F., Terre'Blanche G., Castagnoli N. Jr., Bergh J. J., Petzer J. P., Bioorg. Med. Chem., 15, 3692-3702 (2007).
20. Kalla R. V., Elzein E., Perry T., Li X., Palle V., Varkhedkar V., Gimbel A., Maa T., Zeng D., Zablocki J., J. Med. Chem., 49, 3682-3692 (2006).
21. Xu Y., Ku B. S., Yao H. Y., Lin Y. H., Ma X., Zhang Y. H., Li X. J., Pharmacol. Biochem. Behav., 82, 200-206 (2005).
22. Xu Y., Wang Z. C., You W. T., Zhang X. H., Li S., Barish P. A., Vernon M. M., Du X., Li G., Pan J., Ogle W. O., Eur. Neuropsychopharmacol., 20, 405-413 (2010).
23. La Regina G., Silvestri R., Artico M., Lavecchia A., Novellino E., Befani O., Turini P., Agostinelli E., J. Med. Chem., 50, 922-931 (2007).